Hunan Hansen Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Hunan Hansen Pharmaceutical has a total shareholder equity of CN¥2.0B and total debt of CN¥95.1M, which brings its debt-to-equity ratio to 4.7%. Its total assets and total liabilities are CN¥2.4B and CN¥362.7M respectively. Hunan Hansen Pharmaceutical's EBIT is CN¥191.3M making its interest coverage ratio -3.6. It has cash and short-term investments of CN¥273.8M.
Key information
4.7%
Debt to equity ratio
CN¥95.12m
Debt
Interest coverage ratio | -3.6x |
Cash | CN¥273.82m |
Equity | CN¥2.03b |
Total liabilities | CN¥362.72m |
Total assets | CN¥2.39b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002412's short term assets (CN¥948.4M) exceed its short term liabilities (CN¥342.6M).
Long Term Liabilities: 002412's short term assets (CN¥948.4M) exceed its long term liabilities (CN¥20.1M).
Debt to Equity History and Analysis
Debt Level: 002412 has more cash than its total debt.
Reducing Debt: 002412's debt to equity ratio has reduced from 18.5% to 4.7% over the past 5 years.
Debt Coverage: 002412's debt is well covered by operating cash flow (116.7%).
Interest Coverage: 002412 earns more interest than it pays, so coverage of interest payments is not a concern.